Protocatechuic Acid: Inhibition of Fibril Formation, Destabilization of Preformed Fibrils of Amyloid-β and α-Synuclein, and Neuroprotection

被引:69
|
作者
Hornedo-Ortega, Ruth [1 ]
Antonia Alvarez-Fernandez, Maria [1 ]
Belen Cerezo, Ana [1 ]
Richard, Tristan [2 ]
Maria Troncoso, Ana [1 ]
Carmen Garcia-Parrilla, Maria [1 ]
机构
[1] Univ Seville, Fac Pharm, Area Nutr & Food Sci, C-P Garcia Gonzalez 2, E-41012 Seville, Spain
[2] Univ Bordeaux, ISVV Bordeaux Aquitaine, 71 Ave Edouard Bourleaux, F-33883 Villenave Dornon, France
关键词
neurodegeneration; toxicity; protocatechuic acid; amyloid-beta; alpha-synuclein; CYANIDIN; 3-O-GLUCOPYRANOSIDE; IN-VITRO; ANTHOCYANINS; METABOLISM; ABSORPTION; PHARMACOKINETICS; CONSUMPTION; PHENOLICS; PROTECTS;
D O I
10.1021/acs.jafc.6b03217
中图分类号
S [农业科学];
学科分类号
09 ;
摘要
Protocatechuic acid (PCA) is the major metabolite of the anthocyanin known as cyanidin 3-glucoside. It is found in plasma and tissues, such as the brain, heart, liver, and kidneys, following consumption of a rich source of this flavonoid. The abnormal pathological assembly of amyloid-beta (A beta) and alpha-synuclein (alpha S) is an underlying mechanism involved in the formation of amyloid plaques and Lewy bodies in the brain, which are responsible for neuropathology symptoms in Alzheimer's (AD) and Parkinson's diseases (PD), respectively. This research was performed to evaluate the protective effects of PCA, by establishing its potential role in inhibiting aggregation and fibril destabilization of A beta and alpha S proteins. It has been found that PCA inhibits the aggregation of A beta and alpha S and destabilizes their preformed fibrils. These results were confirmed by TEM images, electrophoresis, and immunoblotting experiments. Furthermore, PCA prevents the death of PC12 cells triggered by A beta- and alpha S-induced toxicity.
引用
收藏
页码:7722 / 7732
页数:11
相关论文
共 50 条
  • [1] Inhibition of α-Synuclein Amyloid Fibril Elongation by Blocking Fibril Ends
    Shvadchak, Volodymyr V.
    Afitska, Kseniia
    Yushchenko, Dmytro A.
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2018, 57 (20) : 5690 - 5694
  • [2] Catechol derivatives inhibit the fibril formation of amyloid-β peptides
    Vu Thi Huong
    Shimanouchi, Toshinori
    Shimauchi, Naoya
    Yagi, Hisashi
    Umakoshi, Hiroshi
    Goto, Yuji
    Kuboi, Ryoichi
    JOURNAL OF BIOSCIENCE AND BIOENGINEERING, 2010, 109 (06) : 629 - 634
  • [3] Computational Insight into the Effect of Natural Compounds on the Destabilization of Preformed Amyloid-β(1-40) Fibrils
    Tavanti, Francesco
    Pedone, Alfonso
    Menziani, Maria Cristina
    MOLECULES, 2018, 23 (06):
  • [4] Inhibition of amyloid fibril formation and cytotoxicity by caffeic acid-conjugated amyloid-β C-terminal peptides
    Arai, Takuya
    Ohno, Akiko
    Mori, Kazunori
    Kuwata, Hiroshi
    Mizuno, Mirei
    Imai, Kohei
    Hara, Shuntaro
    Shibanuma, Motoko
    Kurihara, Masaaki
    Miyata, Naoki
    Nakagawa, Hidehiko
    Fukuhara, Kiyoshi
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (22) : 5468 - 5471
  • [5] Black Tea Theaflavins Inhibit Formation of Toxic Amyloid-β and α-Synuclein Fibrils
    Grelle, Gerlinde
    Otto, Albrecht
    Lorenz, Mario
    Frank, Ronald F.
    Wanker, Erich E.
    Bieschke, Jan
    BIOCHEMISTRY, 2011, 50 (49) : 10624 - 10636
  • [6] Comparison of α-Synuclein Fibril Inhibition by Four Different Amyloid Inhibitors
    Jha, Narendra Nath
    Kumar, Rakesh
    Panigrahi, Rajlaxmi
    Navalkar, Ambuja
    Ghosh, Dhiman
    Sahay, Shruti
    Mondal, Mritunjoy
    Kumar, Ashutosh
    Maji, Samir. K.
    ACS CHEMICAL NEUROSCIENCE, 2017, 8 (12): : 2722 - 2733
  • [7] Modeling α-Synucleinopathy in Organotypic Brain Slice Culture with Preformed α-Synuclein Amyloid Fibrils
    Roux, Amandine
    Wang, Xinhe
    Becker, Katelyn
    Ma, Jiyan
    JOURNAL OF PARKINSONS DISEASE, 2020, 10 (04) : 1397 - 1410
  • [8] Copper Abolishes the β-Sheet Secondary Structure of Preformed Amyloid Fibrils of Amyloid-β42
    House, Emily
    Mold, Matthew
    Collingwood, Joanna
    Baldwin, Alex
    Goodwin, Steven
    Exley, Christopher
    JOURNAL OF ALZHEIMERS DISEASE, 2009, 18 (04) : 811 - 817
  • [9] Polyphenol-solubility alters amyloid fibril formation of α-synuclein
    So, Masatomo
    Kimura, Yuto
    Yamaguchi, Keiichi
    Sugiki, Toshihiko
    Fujiwara, Toshimichi
    Aguirre, Cesar
    Ikenaka, Kensuke
    Mochizuki, Hideki
    Kawata, Yasushi
    Goto, Yuji
    PROTEIN SCIENCE, 2021, 30 (08) : 1701 - 1713
  • [10] Structural and mechanistic insights into amyloid-β and α-synuclein fibril formation and polyphenol inhibitor efficacy in phospholipid bilayers
    Sanders, Henry M.
    Jovcevski, Blagojce
    Marty, Michael T.
    Pukala, Tara L.
    FEBS JOURNAL, 2022, 289 (01) : 215 - 230